Showing results (1621-1630 of 1,659) with videos related to

Sort By:
Pageof 166
Human Molecular Genetics|November 11, 2008
Variants of the elongator protein 3 (ELP3) gene are associated with motor neuron degenerationClaire L Simpson, Robin Lemmens, Katarzyna Miskiewicz, et al.
Blood Advances|August 8, 2022
Early cytopenias and infections after standard of care idecabtagene vicleucel in relapsed or refractory multiple myelomaJennifer M Logue, Lauren C Peres, Hamza Hashmi, et al.
Ebiomedicine|May 30, 2025
Distinct brain atrophy progression subtypes underlie phenoconversion in isolated REM sleep behaviour disorderStephen Joza, Aline Delva, Christina Tremblay, et al.
Journal of Medicinal Chemistry|September 10, 2024
Contilisant+Tubastatin A Hybrids: Polyfunctionalized Indole Derivatives as New HDAC Inhibitor-Based Multitarget Small Molecules with <i>In Vitro</i> and <i>In Vivo</i> Activity in Neurodegenerative DiseasesMireia Toledano-Pinedo, Alicia Porro-Pérez, Linda Schäker-Hübner, et al.
Cell Reports|December 17, 2025
A BRN2:MYC transcriptional axis regulates interconversion between therapy-resistant and tumorigenic phenotypes in melanomaYuntian Zhang, Marcus A Urquijo, Rebecca G Zitnay, et al.
Blood|June 20, 2026
Expanded antigen-specific donor regulatory T cells for GVHD preventionJoseph A Pidala, Nicoletta Cieri, Michael J Schell, et al.
Blood Advances|August 28, 2025
Safety and Efficacy of BCMA directed Chimeric Antigen Receptor T-Cell Therapy for the Treatment of Plasma Cell LeukemiaGliceida M Galarza Fortuna, Lauren C Peres, Elena Nazarenko, et al.
Diabetes|August 11, 2021
Distinct Molecular Signatures of Clinical Clusters in People With Type 2 Diabetes: An IMI-RHAPSODY StudyRoderick C Slieker, Louise A Donnelly, Hugo Fitipaldi, et al.
Matrix Biology : Journal of the International Society for Matrix Biology|June 13, 2024
The fibroblast hormone Endotrophin is a biomarker of mortality in chronic diseasesFederica Genovese, Cecilie Bager, Peder Frederiksen, et al.
Haematologica|July 10, 2025
Cytopenias and infections following ciltacabtagene autoleucel in heavily-pretreated relapsed or refractory multiple myelomaDanai Dima, Jennifer M Logue, Syed Hamza Bin Waqar, et al.
Pageof 166